Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced funding support for a new clinical trial. Led by sickle cell disease (SCD) experts at France’s Henri Mondor ...
Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...
Domino Printing Sciences’ (Domino) newly launched, next-generation CO2 laser coders, the Dx-Series, are positioned to help beverage manufacturers prepare for future high-resolution coding requirements ...
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies, announces the appointment of Eckhard Niemeier as its Chief Business ...
Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for Advanced Therapy Medical Products (ATMPs), announced ...
New results from the RESOLUTION trial demonstrate the efficacy of Vyepti® (eptinezumab) on top of patient education for patients severely impacted by migraine, with the placebo-controlled Phase IV ...